LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.22 | 27.76 | 413 | 4125 | 0.1001 | 0.4538 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.22 | 27.76 | 1788 | 4125 | 0.4335 | 0.7812 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.22 | 27.76 | 172 | 4125 | 0.0417 | 0.2876 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.22 | 27.76 | 1881 | 4125 | 0.4560 | 0.7938 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.93 | 27.76 | 429 | 4421 | 0.0970 | 0.4539 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.93 | 27.76 | 1846 | 4421 | 0.4175 | 0.7749 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.93 | 27.76 | 206 | 4421 | 0.0466 | 0.3152 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.93 | 27.76 | 1972 | 4421 | 0.4460 | 0.7910 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.63 | 27.76 | 468 | 4818 | 0.0971 | 0.4619 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.63 | 27.76 | 1942 | 4818 | 0.4031 | 0.7701 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.63 | 27.76 | 233 | 4818 | 0.0484 | 0.3311 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.63 | 27.76 | 2068 | 4818 | 0.4292 | 0.7851 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.33 | 27.76 | 481 | 5117 | 0.0940 | 0.4608 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.33 | 27.76 | 2020 | 5117 | 0.3948 | 0.7676 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.33 | 27.76 | 244 | 5117 | 0.0477 | 0.3348 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.33 | 27.76 | 2105 | 5117 | 0.4114 | 0.7774 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.04 | 27.76 | 485 | 5365 | 0.0904 | 0.4574 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.04 | 27.76 | 2101 | 5365 | 0.3916 | 0.7677 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.04 | 27.76 | 247 | 5365 | 0.0460 | 0.3335 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.04 | 27.76 | 2168 | 5365 | 0.4041 | 0.7750 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.74 | 27.76 | 504 | 5606 | 0.0899 | 0.4602 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.74 | 27.76 | 2183 | 5606 | 0.3894 | 0.7682 | MN20160318_Q01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.74 | 27.76 | 242 | 5606 | 0.0432 | 0.3268 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.74 | 27.76 | 2233 | 5606 | 0.3983 | 0.7735 | MN20160318_Q01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.45 | 27.76 | 555 | 5745 | 0.0966 | 0.4760 | MN20160318_Q01 | J22 |